The hedge fund's founder, Alex Denner, 53, one of three Sarissa candidates running for seats on Alkermes' 11-member board, on Monday said he would give up his board seat at biotech company Biogen (BIIB.O).
The move eliminates "any claim of conflict whatsoever," Sarissa wrote to Alkermes shareholders on Tuesday.
Alkermes shareholders will vote on directors on June 29 in what is one of the year's five biggest boardroom challenges.
A Biogen representative confirmed that the board knew about the relationship between Denner and Langer.
Denner, who has served on the Biogen board since 2009 and headed the nominating and governance committee, had nominated Langer.
Persons:
Alex Denner, Sarissa, Biogen, Susan Langer, Alkermes, Denner, Langer, Bob Langer, Biogen's, Stelios Papadopoulos, Caroline Dorsa, Richard Mulligan, William Jones, Svea Herbst, Bayliss, Bill Berkrot, Mark Porter, Leslie Adler
Organizations:
YORK, Management, Moderna, Svea, Thomson
Locations:
Alkermes, Biogen